This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, United Kingdom, United States
The drug RUBRACA contains one active pharmaceutical ingredient (API):
1
Rucaparib
UNII 41AX9SJ8KO - RUCAPARIB CAMSYLATE
|
Rucaparib is an inhibitor of poly(ADP-ribose) polymerase (PARP) enzymes, including PARP-1, PARP-2, and PARP-3, which play a role in DNA repair. In vitro studies have shown that rucaparibinduced cytotoxicity involves inhibition of PARP enzymatic activity and the trapping of PARP-DNA complexes resulting in increased DNA damage, apoptosis, and cell death. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
RUBRACA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
L01XK03 | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1773806, 1773817, 1773828 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1171250001, 1171250002, 1171250003 |
Country: FR | Base de données publique des médicaments | Identifier(s): 60261656, 60980609, 69586252 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 358195, 358199, 358203 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8460, 8470, 8471 |
Country: IT | Agenzia del Farmaco | Identifier(s): 046645014, 046645026, 046645038 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1085748, 1085749, 1085750 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 196916, 196924, 196932 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100418021, 100418038, 100418044 |
Country: US | FDA, National Drug Code | Identifier(s): 69660-201, 69660-202, 69660-203 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.